Cargando…

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer

BACKGROUND: Transmembrane p24 trafficking protein (TMED) family members are implicated in several solid tumors, but their clinical relevance for breast cancer (BC) remains unclear. This study aimed to probe their prognostic values and relations with tumor immunity in BC. METHODS: TMED family mRNA ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Zheng, Song, Yu-Xin, Wo, Guan-Qun, Zhou, Hong-Lei, Li, Lei, Yang, Si-Yuan, Chen, Xiu, Zhang, Jian, Tang, Jin-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816852/ https://www.ncbi.nlm.nih.gov/pubmed/36618780 http://dx.doi.org/10.21037/atm-22-5444

Ejemplares similares

TMED family genes and their roles in human diseases
por: Zhou, Lv, et al.
Publicado: (2023)

The circular RNA CDR1as regulate cell proliferation via TMED2 and TMED10
por: Yang, Xue, et al.
Publicado: (2020)

Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells
por: Yang, Jinxing, et al.
Publicado: (2021)

Unconventional secretion: cargo channeling by TMED10
por: Nguyen, Tan A., et al.
Publicado: (2020)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Expression of TMED3 is independently associated with colorectal cancer prognosis
por: Wang, Rong-Fei, et al.
Publicado: (2022)

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases
por: Mishra, Sonakshi, et al.
Publicado: (2019)

TMED2 promotes epithelial ovarian cancer growth
por: Shi-Peng, Gong, et al.
Publicado: (2017)

Expression and Importance of TMED2 in Multiple Myeloma Cells
por: Ge, Xueling, et al.
Publicado: (2020)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

TMED2 as a marker of prognosis in breast cancer [Letter]
por: Schwarz, Megan Catherine, et al.
Publicado: (2019)

TMED2 binding restricts SMO to the ER and Golgi compartments
por: Di Minin, Giulio, et al.
Publicado: (2022)

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
por: Yang, Yi-Chieh, et al.
Publicado: (2021)

RAB21 interacts with TMED10 and modulates its localization and abundance
por: Del Olmo, Tomas, et al.
Publicado: (2019)

The many hats of transmembrane emp24 domain protein TMED9 in secretory pathway homeostasis
por: Roberts, Benjamin S., et al.
Publicado: (2023)

TMED3 Promotes Proliferation and Migration in Breast Cancer Cells by Activating Wnt/β-Catenin Signaling
por: Zhang, Xiumei, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2
por: Hou, Wenyang, et al.
Publicado: (2017)

Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer
por: Lin, Xia, et al.
Publicado: (2019)

TMED3/RPS15A Axis promotes the development and progression of osteosarcoma
por: Xu, Wei, et al.
Publicado: (2021)

TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR
por: Xie, An, et al.
Publicado: (2021)

Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer
por: Sial, Nuzhat, et al.
Publicado: (2021)

A new type of ERGIC–ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis
por: Li, Shulin, et al.
Publicado: (2021)

TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling
por: Zheng, Hao, et al.
Publicado: (2016)

TMED3 Complex Mediates ER Stress‐Associated Secretion of CFTR, Pendrin, and SARS‐CoV‐2 Spike
por: Park, Hak, et al.
Publicado: (2022)

Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis
por: Ha, Mihyang, et al.
Publicado: (2019)

TMED10 mediates the trafficking of insulin-like growth factor 2 along the secretory pathway for myoblast differentiation
por: Li, Tiantian, et al.
Publicado: (2023)

Circular RNA circ_0008305 aggravates hepatocellular carcinoma growth through binding to miR‐186 and inducing TMED2
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

TP73-AS1 promotes gastric cancer proliferation and invasion by regulation miR-27b-3p/TMED5 axis
por: Bao, Chenhui, et al.
Publicado: (2022)

TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p
por: Pei, Jing, et al.
Publicado: (2019)

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
por: Guo, Xianling, et al.
Publicado: (2023)

Identification of a novel circ_0018289/miR-183-5p/TMED5 regulatory network in cervical cancer development
por: Zou, Heng, et al.
Publicado: (2021)

High-Throughput Transcriptomic and RNAi Analysis Identifies AIM1, ERGIC1, TMED3 and TPX2 as Potential Drug Targets in Prostate Cancer
por: Vainio, Paula, et al.
Publicado: (2012)

A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12
por: Duquet, Arnaud, et al.
Publicado: (2014)

Transmembrane p24 trafficking protein 10 (TMED10) inhibits mitochondrial damage and protects neurons in ischemic stroke via the c-Jun N-terminal kinase (JNK) signaling pathway
por: Li, Qiushi, et al.
Publicado: (2022)

Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion
por: Meng, Fei, et al.
Publicado: (2016)

Knockdown of FOXK1 Suppresses Proliferation, Migration, and Invasion in Prostate Cancer Cells
por: Chen, Fang, et al.
Publicado: (2017)

Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer
por: Yang, Xueqing, et al.
Publicado: (2020)

Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway
por: Wang, Yu, et al.
Publicado: (2016)

Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer
por: Wei, Yongqing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ui2la385qvmrnnbhcvsge4jdnk